Clinical Trial

Ayahuasca, Esketamine and PTSD

Name: Ayahuasca, Esketamine and PTSD — clinical trial record (NCT07317206)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated January 5, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Summary

Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.

Trial Details

NCT Number	NCT07317206
Lead Sponsor	University of Sao Paulo
Conditions	Posttraumatic Stress Disorder (PTSD)
Enrollment	10 participants
Start Date	2025-12-20
Primary Completion	2026-06 (estimated)
Study Completion	2026-07 (estimated)
Updated on ClinicalTrials.gov	2026-01-05